{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:44:27Z","timestamp":1792100667902,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2022-82274451"],"award-info":[{"award-number":["2022-82274451"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2022CRD003"],"award-info":[{"award-number":["SHDC2022CRD003"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2022CRW006"],"award-info":[{"award-number":["SHDC2022CRW006"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.biopha.2023.116107","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T23:13:25Z","timestamp":1704928405000},"page":"116107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Additive renal protective effects between arctigenin and puerarin in diabetic kidney disease"],"prefix":"10.1016","volume":"171","author":[{"given":"Xueling","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Cijiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4759-3758","authenticated-orcid":false,"given":"Yifei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.116107_bib1","unstructured":"USRDS. Annual Data Report: Atlas of End-Stage-Renal-Disease in the United States (2011)."},{"key":"10.1016\/j.biopha.2023.116107_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.kint.2020.10.003","article-title":"Therapeutic transformation for diabetic kidney disease","volume":"99","author":"Tuttle","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2023.116107_bib4","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.116107_bib5","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s10753-015-0115-3","article-title":"Arctigenin protects against lipopolysaccharide-induced pulmonary oxidative stress and inflammation in a mouse model via suppression of MAPK, HO-1, and iNOS signaling","volume":"38","author":"Zhang","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2023.116107_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jep.2009.01.038","article-title":"In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway","volume":"122","author":"Zhao","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2023.116107_bib7","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/febs.13573","article-title":"All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase","volume":"283","author":"Sangodkar","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2023.116107_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12433-w","article-title":"Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes","volume":"10","author":"Zhong","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.116107_bib9","first-page":"3","article-title":"Clinical investigation of stage-IV diabetic nephropathy with treatment of Chen's Tangshen decoction and conventional Western medicine","volume":"44","author":"lian","year":"2010","journal-title":"Shanghai J. Tradit. Chin. Med."},{"key":"10.1016\/j.biopha.2023.116107_bib10","article-title":"Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats","volume":"9","author":"Zhong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.116107_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.gene.2016.06.032","article-title":"Puerarin, isolated from Pueraria lobata (Willd.), protects against diabetic nephropathy by attenuating oxidative stress","volume":"591","author":"Xu","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2023.116107_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3109\/0886022X.2015.1011500","article-title":"The Puerarin improves renal function in STZ-induced diabetic rats by attenuating eNOS expression","volume":"37","author":"Zhang","year":"2015","journal-title":"Ren. Fail."},{"key":"10.1016\/j.biopha.2023.116107_bib13","first-page":"481","article-title":"[Effects of puerarin on renal function, expressions of MMP-2 and TIMP-2 in diabetic rats]","volume":"39","author":"Duan","year":"2004","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.biopha.2023.116107_bib14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.fct.2014.06.017","article-title":"Puerarin ameliorates carbon tetrachloride-induced oxidative DNA damage and inflammation in mouse kidney through ERK\/Nrf2\/ARE pathway","volume":"71","author":"Ma","year":"2014","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"key":"10.1016\/j.biopha.2023.116107_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.taap.2009.12.023","article-title":"Puerarin suppresses AGEs-induced inflammation in mouse mesangial cells: a possible pathway through the induction of heme oxygenase-1 expression","volume":"244","author":"Kim","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2023.116107_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17925-7","article-title":"Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.116107_bib17","article-title":"Puerarin attenuates diabetic nephropathy by promoting autophagy in podocytes","volume":"11","author":"Li","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2023.116107_bib18","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1111\/jcmm.17414","article-title":"Puerarin attenuates diabetic kidney injury through interaction with Guanidine nucleotide-binding protein Gi subunit alpha-1 (Gnai1) subunit","volume":"26","author":"Zhu","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2023.116107_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075687","article-title":"Blockade of the formation of insoluble ubiquitinated protein aggregates by EGCG3\"Me in the alloxan-induced diabetic kidney","volume":"8","author":"Cai","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.116107_bib20","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1062374","article-title":"Duration of nuclear NF-kappaB action regulated by reversible acetylation","volume":"293","author":"Chen","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.biopha.2023.116107_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/0470862637.ch15","article-title":"Regulation of NF-kappaB action by reversible acetylation","volume":"259","author":"Greene","year":"2004","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.biopha.2023.116107_bib22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.7150\/thno.63735","article-title":"Tubular epithelial cell-to-macrophage communication forms a negative feedback loop via extracellular vesicle transfer to promote renal inflammation and apoptosis in diabetic nephropathy","volume":"12","author":"Jiang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2023.116107_bib23","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/ndt\/gfh207","article-title":"NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy","volume":"19","author":"Mezzano","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.biopha.2023.116107_bib24","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1681\/ASN.2016101101","article-title":"Plasma biomarkers and kidney function decline in early and established diabetic kidney disease","volume":"28","author":"Coca","year":"2017","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"key":"10.1016\/j.biopha.2023.116107_bib25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.ajkd.2021.09.018","article-title":"Associations of plasma biomarkers of inflammation, fibrosis, and kidney tubular injury with progression of diabetic kidney disease: a cohort study","volume":"79","author":"Guti\u00e9rrez","year":"2022","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"10.1016\/j.biopha.2023.116107_bib26","unstructured":"National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals., Institute for Laboratory Animal Research (U.S.) & National Academies Press (U.S.). Guide for the Care and Use of Laboratory Animals, National Academies Press, Washington, D.C., xxv, 220 2011)."},{"key":"10.1016\/j.biopha.2023.116107_bib27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/ndt\/9.3.304","article-title":"Optimal method for RNA extraction from mouse glomeruli","volume":"9","author":"Baelde","year":"1994","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.biopha.2023.116107_bib28","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/ki.2012.445","article-title":"Expression of HIV transgene aggravates kidney injury in diabetic mice","volume":"83","author":"Mallipattu","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2023.116107_bib29","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.ki.5002456","article-title":"Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor","volume":"72","author":"Chuang","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2023.116107_bib30","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","article-title":"A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression","volume":"13","author":"Saleem","year":"2002","journal-title":"J. Am. Soc. Nephrol. JASN"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223019054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223019054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:50:44Z","timestamp":1792097444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223019054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":29,"alternative-id":["S0753332223019054"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.116107","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Additive renal protective effects between arctigenin and puerarin in diabetic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.116107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116107"}}